Hesai Selected by Top European OEM For Exclusive Multi-Year Lidar Contract On Its Next-Generation Global Platform
PALO ALTO, Calif., March 11, 2025 /PRNewswire/ -- Hesai Technology (NASDAQ: HSAI), the global leader in lidar technology for automotive mobility and robotics applications, announced today a new exclusive design win with a leading European OEM. Hesai...
Macronix OctaFlash Provides High-Performance Memory for New STMicroelectronics' STM32N6 AI-Accelerated MCU Platform
1Gb OctaFlash™ Memory Helps Enable Advanced AI Applications, 3D-like GUI Experience HSINCHU, March 11, 2025 /PRNewswire/ -- Macronix International Co., Ltd. (TSE: 2337), a leading integrated device manufacturer in the non-volatile memory (NVM)...
Utility Achieves Industry-First Hydrogen Production Using Steel Manufacturing Off-Gases
Onsite hydrogen production using industrial off-gases now offers a commercially viable, economic clean energy for heavy industry HOUSTON, March 10, 2025 /PRNewswire/ -- Utility, the leader in affordable, reliable and clean hydrogen solutions that...
Visionary Takes the Lead in the New Energy Vehicle Field and Builds an Innovative Industrial Ecosystem
TORONTO, March 10, 2025 /PRNewswire/ -- Recently, Visionary announced that it will make a major foray into the new energy vehicle industry and build a unique integrated industrial ecosystem of "vehicle-station-power-cloud-research-finance". It is...
Yum China Appoints Adrian Ding as Chief Financial Officer
SHANGHAI, March 10, 2025 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE: YUMC and HKEX: 9987) announced that after a thorough search process, Adrian Ding has been appointed as Chief Financial Officer, effective on...
Lundbeck's potential treatment for Multiple System Atrophy granted Orphan Drug Designation in Japan
VALBY, Denmark, March 10, 2025 /PRNewswire/ -- The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multiple...
RiboX Therapeutics Announces First Patient Dosed in Phase I/IIa Clinical Trial of RXRG001, the First Circular RNA Therapy for the Treatment of Radiation-Induced Xerostomia and Hyposalivation
PRINCETON, N.J., March 10, 2025 /PRNewswire/ -- RiboX Therapeutics Ltd. (RiboX), a pioneering biopharmaceutical company, focused on discovering and developing fully engineered circular RNA therapeutics, today announced that the first patient was...
SU Group Secures Top Multi-Purpose Sports Venue
HONG KONG, March 7, 2025 /PRNewswire/ -- SU Group Holdings Limited (Nasdaq: SUGP) ("SU Group" or the "Company"), an integrated security-related engineering services company in Hong Kong, today announced it provided critical access control gates that...
HERO ESPORTS Asian Champions League: Dota 2 Tournament Champions Secure Place in Esports World Cup
SHANGHAI, March 7, 2025 /PRNewswire/ -- The HERO ESPORTS Asian Champions League (ACL), Asia's premier multi-title esports tournament hosted by Asia's leading esports company Hero Esports, announced that champions of the ACL Dota 2 Tournament will...
Atomicwork Gathers Top CIOs for CIO Advisory Board to Transform Enterprise IT with Agentic Service Management
SAN FRANCISCO, March 7, 2025 /PRNewswire/ -- Atomicwork, a leading innovator in agentic service management solutions for enterprise IT, today announced the formation of its CIO Advisory Board (CAB), bringing together a distinguished group of...